Jennifer Krist
Biographic Data
| ID | 9725245 |
|---|---|
| NAME | Jennifer Krist |
| GIVEN NAMES | Jennifer |
| FAMILY NAME | Krist |
| SIGNATURE | KRIST J |
| AFFILIATIONS | University of British Columbia |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
HPV Vaccine and College-Age Men
The human papillomavirus (HPV) potentially affects every sexually active man in the United States and Canada. In 2017, the vaccine became publicly funded in Canada for males ages 9–26, and was integrated into school vaccination programs. In 2019, HPV vaccination was recommended as routine for all U.S.-based males and females ages 9 through 26, and a shared decision for adults >26 years; however, since the approval of the vaccine in 2006 for femal…
Bridging Barriers to Cervical Cancer Screening in Transgender Men
Estimates of high-risk human papillomavirus (HPV) infection and susceptibility to HPV-related cancer in transgender men (TM) are comparable to prevalence rates found in cisgender women. Regular and thorough screening for cervical cancer is equally as crucial for TM as for cisgender women; however, despite continued risk for cervical cancer in TM and associated recommendations for screening, studies indicate disparities in rates of cervical cancer…
No prominent works on this page.
HPV Vaccine and College-Age Men
The human papillomavirus (HPV) potentially affects every sexually active man in the United States and Canada. In 2017, the vaccine became publicly funded in Canada for males ages 9–26, and was integrated into school vaccination programs. In 2019, HPV vaccination was recommended as routine for all U.S.-based males and females ages 9 through 26, and a shared decision for adults >26 years; however, since the approval of the vaccine in 2006 for femal…
Bridging Barriers to Cervical Cancer Screening in Transgender Men
Estimates of high-risk human papillomavirus (HPV) infection and susceptibility to HPV-related cancer in transgender men (TM) are comparable to prevalence rates found in cisgender women. Regular and thorough screening for cervical cancer is equally as crucial for TM as for cisgender women; however, despite continued risk for cervical cancer in TM and associated recommendations for screening, studies indicate disparities in rates of cervical cancer…
Cervical Cancer and HPV Research (2 works) · Environmental health (2 works) · Family medicine (2 works) · Medicine (2 works) · Cancer (1 work) · Cervical cancer (1 work) · Demography (1 work) · Feminist Theory and Gender Studies (1 work) · Gerontology (1 work) · Gynecology (1 work)